MP
AGN

MSD Partners’s Allergan plc AGN Stock Holding History

MSD Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-148,500
Closed -$26.3M – 30
2020
Q1 		$26.3M Buy
+148,500
New +$28M 7.11% 4
2019
Q3 		– Sell
-80,000
Closed -$13.4M – 33
2019
Q2 		$13.4M Buy
+80,000
New +$11.1M 1.62% 11

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

MSD Partners's AGN Position: Q2 2020 in Review

MSD Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 148,500 shares — an estimated $26.3M sold.

MSD Partners first reported a position in AGN in Q2 2019 and held it in 2 quarters. The position peaked at $26.3M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • MSD Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • MSD Partners sold 148,500 Allergan plc shares in Q2 2020, an estimated $26.3M.
  • MSD Partners first reported a position in Allergan plc in Q2 2019 and held it in 2 quarters.
  • MSD Partners's Allergan plc position peaked at $26.3M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on MSD Partners's 13F filing for Q2 2020, filed 14 Aug 2020.